Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas (NCT00095771)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2004-11-01
Insulin Glulisine in Type 2 Diabetes Mellitus (NCT00310297)Sanofi2004-11-01
BN80927 in Patients With Advanced Malignant Solid Tumors (NCT01435096)Ipsen2004-11-01
A Study to Assess the Effects of a Light Breakfast on the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) (NCT00863525)Merck Sharp & Dohme LLC2004-11-01
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 (NCT02127372)Duke University2004-11-01
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions (NCT01190748)Actavis Inc.2004-11-01
Assessment of Fibrin Glue in Pterygium Surgery and Other Forms of External Eye Surgery (NCT00344201)Singapore National Eye Centre2004-11-01
SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma (NCT00101244)National Cancer Institute (NCI)2004-11-01
Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours (NCT02171702)Boehringer Ingelheim2004-11-01
Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb (NCT00500786)Cytos Biotechnology AG2004-11-01
Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients (NCT00089466)National Institute of Allergy and Infectious Diseases (NIAID)2004-11-01
SJG-136 in Treating Patients With Advanced Solid Tumors (NCT00103220)National Cancer Institute (NCI)2004-11-01
An Autism Study Using Nambudripad's Food Allergy Elimination Treatments (NCT00247156)Nambudripad's Allergy Research Foundation2004-11-01
Endothelial Modulation for Angiogenic Therapy (NCT00134433)Ottawa Heart Institute Research Corporation2004-11-01
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers (NCT00095862)Wiseman Research Initiatives LLC2004-11-01
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions (NCT01581866)Dr. Reddy's Laboratories Limited2004-11-01
Brief Interventions for Drop-out Re-engagement (NCT00350571)Yale University2004-11-01
The Effect of Mifepristone on Uterine Fibroids and Breast Tissue (NCT00579475)Karolinska Institutet2004-11-01
Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients (NCT00303641)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2004-11-01
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes (NCT00098423)National Cancer Institute (NCI)2004-11-01
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT00101205)National Cancer Institute (NCI)2004-11-01
Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease (NCT00095472)National Heart, Lung, and Blood Institute (NHLBI)2004-11-01
Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer (NCT01510288)Amsterdam UMC, location VUmc2004-11-01
A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00138658)Achieve Life Sciences2004-11-01
Visual Cortex Stimulation in Patients With Amblyopia (NCT00097162)National Eye Institute (NEI)2004-11-01
Sports to Prevent Obesity: Feasibility and Pilot RCT (NCT00186173)Stanford University2004-11-01
A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) (NCT00102505)Pharmacyclics LLC.2004-11-01
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression (NCT00566813)University of Illinois at Chicago2004-11-01
Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00096005)National Cancer Institute (NCI)2004-11-01
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin (NCT01785615)University of Rochester2004-11-01
Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors (NCT00100880)National Cancer Institute (NCI)2004-11-01
Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma (NCT00098332)BioCryst Pharmaceuticals2004-11-01
Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00238225)Roswell Park Cancer Institute2004-11-01
Effect of Methylnaltrexone (MNTX) on Electrocardiogram (ECG) Parameters and Cardiac Repolarization (NCT01363323)Bausch Health Americas, Inc.2004-11-01
Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers (NCT02254226)Boehringer Ingelheim2004-11-01
Differentiation Induction in Acute Myelogenous Leukemia (NCT00175812)University of Bergen2004-11-01
A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma (NCT00199342)Kyowa Kirin, Inc.2004-11-01
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Syndrome, Refractory CLL and PLL (NCT00452374)M.D. Anderson Cancer Center2004-11-01
Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma (NCT00112827)City of Hope Medical Center2004-11-01
A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (NCT00363714)Allergan2004-11-01
Dose Escalation Study of Continuous Once-daily Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171728)Boehringer Ingelheim2004-11-01
FMP2.1/AS02A: Rabies Vaccine Malaria-Experienced Adults in Bandiagara, Mali (NCT00349713)U.S. Army Medical Research and Development Command2004-11-01
A Study to Test Once-Weekly Doses of Odanacatib (MK0822) on Healthy Adult Females (0822-005)(COMPLETED) (NCT00770159)Merck Sharp & Dohme LLC2004-11-01
Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V (NCT00097396)DynPort Vaccine Company LLC, A GDIT Company2004-11-01
A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease (NCT00229736)Genzyme, a Sanofi Company2004-11-01
Study Evaluating CMD-193 in Advanced Malignant Solid Tumors (NCT00161642)Wyeth is now a wholly owned subsidiary of Pfizer2004-11-01
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC (NCT00378404)Susanne Arnold2004-11-01
A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions (NCT00870480)Actavis Inc.2004-11-01
A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults (NCT00701493)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2004-11-01
Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma (NCT00101309)Milton S. Hershey Medical Center2004-11-01
Wheal and Flare Reaction During 24 Hours in Allergic Volunteers. (NCT00521170)UCB Pharma2004-11-01
Pilot Community Clinical Study of Hypothermia in Cardiac Arrest (NCT00329563)University of Washington2004-11-01
Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg (NCT00650247)Mylan Pharmaceuticals Inc2004-11-01
Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg (NCT00650533)Mylan Pharmaceuticals Inc2004-11-01
Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg (NCT00648362)Mylan Pharmaceuticals Inc2004-11-01
An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease (NCT00091845)Sarepta Therapeutics, Inc.2004-11-01
Study of XL999 in Adults With Solid Tumors (NCT00104117)Symphony Evolution, Inc.2004-11-01
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK0683 in Patients With Advanced Cancer (0683-008) (NCT00750178)Merck Sharp & Dohme LLC2004-11-01
Nursing-Home Residents Given Bread Fortified With Vitamin D3 (NCT00789503)University of Toronto2004-11-01
Doxil® + Melphalan + Velcade (DMV) in Relapsed/Refractory Multiple Myeloma (NCT00985907)University of California, San Francisco2004-10-28
Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer (NCT00292045)Ludwig Institute for Cancer Research2004-10-27
Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum (NCT00094978)National Cancer Institute (NCI)2004-10-25
MRI-Guided Balloon Angioplasty to Treat Blood Flow Blockage in the Legs (NCT00094783)National Heart, Lung, and Blood Institute (NHLBI)2004-10-20
Ispinesib In Combination With Carboplatin In Patients With Solid Tumors (NCT00136578)GlaxoSmithKline2004-10-20
Cyclosporine Implant for Ocular Graft-Versus-Host Disease (NCT00102583)National Eye Institute (NEI)2004-10-14
Carbon Monoxide to Prevent Lung Inflammation (NCT00094406)National Institutes of Health Clinical Center (CC)2004-10-13
Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer (NCT00159484)University of Southern California2004-10-12
A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors (NCT00259935)GlaxoSmithKline2004-10-04
Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults (NCT00097838)AlphaVax, Inc.2004-10-01
Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer (NCT00101257)Fred Hutchinson Cancer Center2004-10-01
Trandolapril 4 mg Tablet Under Fasting Conditions (NCT00840632)Teva Pharmaceuticals USA2004-10-01
Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00098462)Jonsson Comprehensive Cancer Center2004-10-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate (NCT00100997)Jonsson Comprehensive Cancer Center2004-10-01
Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions (NCT01131780)Dr. Reddy's Laboratories Limited2004-10-01
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction. (NCT00209144)Emory University2004-10-01
Phase I Study of Interperitoneal Chenotherapy in Patients With Gastric Adenocarainoma With Peritoneal Seeding (NCT00539877)Samsung Medical Center2004-10-01
Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants (NCT00091325)University of Arizona2004-10-01
Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation (NCT00460447)University Hospital Carl Gustav Carus2004-10-01
Outpatient Adolescent Treatment for Comorbid Substance Use and Internalizing Disorders (NCT00438685)Medical University of South Carolina2004-10-01
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus (NCT02443506)Amgen2004-10-01
Ropinirole 0.25 mg Tablets Under Fasting Conditions (NCT00829504)Teva Pharmaceuticals USA2004-10-01
CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors (NCT00098501)National Cancer Institute (NCI)2004-10-01
A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies (NCT00207025)Bristol-Myers Squibb2004-10-01
A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function. (NCT00645437)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2004-10-01
A Study of a Potential Mechanisms of Spinal Manipulation in the Treatment of Low Back Pain (NCT00922220)University of Florida2004-10-01
Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients (NCT00133601)National Institute of Nursing Research (NINR)2004-10-01
Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age (NCT00231920)National Institute of Allergy and Infectious Diseases (NIAID)2004-10-01
Stem Cell Injection for Peripheral Vascular Disease (NCT00278603)Northwestern University2004-10-01
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer (NCT00129025)Alberta Health services2004-10-01
Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors (NCT00094159)Sunesis Pharmaceuticals2004-10-01
Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa (NCT00149786)Stanford University2004-10-01
Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter (NCT00160836)University Hospital, Geneva2004-10-01
Drug Interactions and Bioavailability of Cranberry (NCT00200759)Medical University of South Carolina2004-10-01
A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120 (NCT00715403)Boehringer Ingelheim2004-10-01
Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours (NCT00692354)Chroma Therapeutics2004-10-01
Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition (NCT01372280)Dr. Reddy's Laboratories Limited2004-10-01
Bioavailability Study of Folic Acid in Healthy Women (NCT00709267)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2004-10-01
Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases (NCT00362817)Ohio State University Comprehensive Cancer Center2004-10-01
XK469R in Treating Patients With Refractory Hematologic Cancer (NCT00095797)National Cancer Institute (NCI)2004-10-01
Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment) (NCT00183118)Boston Medical Center2004-10-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.